Apellis Pharmaceuticals (APLS) PT Raised to $80 at Citi
Tweet
Share
E-mailGet Alerts APLS Hot Sheet
Price: $41.03 --0%
Rating Summary:
6 Buy, 23 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 20
Rating Summary:
6 Buy, 23 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 20
Join SI Premium – FREE
Citi analyst Yigal Nochomovitz raised the price target on Apellis Pharmaceuticals (NASDAQ: APLS) to $80.00 (from $37.00) while maintaining a Buy rating.
You May Also Be Interested In
- JPMorgan Upgrades Hyundai Marine and Fire Insurance (001450:KS) to Neutral
- JD Health International Inc (6618:HK) PT Lowered to HK$60 at Nomura/Instinet
- Sunac China Holdings Limited (1918:HK) (SCCCF) PT Lowered to HK$0.30 at JPMorgan
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
